Adam M. Veness - 07 Sep 2021 Form 4 Insider Report for ACCELERON PHARMA INC

Role
SVP, General Counsel and Sec.
Signature
/s/ Adam M. Veness
Issuer symbol
N/A
Transactions as of
07 Sep 2021
Net transactions value
-$259,624
Form type
4
Filing time
09 Sep 2021, 17:07:38 UTC
Previous filing
08 Jun 2021
Next filing
22 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XLRN Common Stock Tax liability $75,934 -587 -2.8% $129.36 20,336 07 Sep 2021 Direct
transaction XLRN Common Stock Sale $780 -6 -0.03% $130.00 20,330 08 Sep 2021 Direct F1
transaction XLRN Common Stock Sale $182,910 -1,407 -6.9% $130.00 18,923 09 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.